Inhibition of JAK/STAT3 signaling by gene silencing or using an IL-6 receptor fusion protein (IL-6RFP), which acts as a cytokine trap to sequester soluble IL-6, exhausts the CSC population in both murine and human prostate cancer models [47]. This evidence concerns the gene STAT3 and prostate carcinoma.